Resultats de la cerca - Chekenya, Martha

Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics per Krakstad, Camilla, Chekenya, Martha

Obtenir text complet Obtenir text complet Obtenir text complet

Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours per Kmiecik, Justyna, Zimmer, Jacques, Chekenya, Martha

Obtenir text complet Obtenir text complet Obtenir text complet

Cancer Stem Cells as Mediators of Treatment Resistance in Brain Tumors: Status and Controversies per Sakariassen, Per Ø, Immervoll, Heike, Chekenya, Martha

Obtenir text complet Obtenir text complet

Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors per Gras Navarro, Andrea, Björklund, Andreas T., Chekenya, Martha

Obtenir text complet Obtenir text complet Obtenir text complet

Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy per Arnesen, Victoria Smith, Gras Navarro, Andrea, Chekenya, Martha

Obtenir text complet Obtenir text complet Obtenir text complet

Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma per Kmiecik, Justyna, Gras Navarro, Andrea, Poli, Aurelie, Planagumà, Jesús Planagumà, Zimmer, Jacques, Chekenya, Martha

Obtenir text complet Obtenir text complet Obtenir text complet

Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors–Human Leukocyte Antig... per Haspels, Heleen Neeltje, Rahman, Mohummad Aminur, Joseph, Justin Vareecal, Gras Navarro, Andrea, Chekenya, Martha

Obtenir text complet Obtenir text complet Obtenir text complet

Novel method for isolating untouched rat natural killer cells with higher purity compared with positive selection and fluorescence-activated cell sorting per Poli, Aurélie, Brons, Nicolaas H C, Ammerlaan, Wim, Michel, Tatiana, Hentges, François, Chekenya, Martha, Zimmer, Jacques

Obtenir text complet Obtenir text complet Obtenir text complet

NK Cells with KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival per Gras Navarro, Andrea, Kmiecik, Justyna, Leiss, Lina, Zelkowski, Mateusz, Engelsen, Agnete, Bruserud, Øystein, Zimmer, Jacques, Enger, Per Øyvind, Chekenya, Martha

Obtenir text complet Obtenir text complet Obtenir text complet

Hyperoxic Treatment Induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model per Moen, Ingrid, Øyan, Anne Margrete, Kalland, Karl-Henning, Tronstad, Karl Johan, Akslen, Lars Andreas, Chekenya, Martha, Sakariassen, Per Øystein, Reed, Rolf Kåre, Stuhr, Linda Elin Birkhaug

Obtenir text complet Obtenir text complet Obtenir text complet

A reproducible brain tumour model established from human glioblastoma biopsies per Wang, Jian, Miletic, Hrvoje, Sakariassen, Per Ø, Huszthy, Peter C, Jacobsen, Hege, Brekkå, Narve, Li, Xingang, Zhao, Peng, Mørk, Sverre, Chekenya, Martha, Bjerkvig, Rolf, Enger, Per Ø

Obtenir text complet Obtenir text complet Obtenir text complet

Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma per Wang, Jian, Svendsen, Agnete, Kmiecik, Justyna, Immervoll, Heike, Skaftnesmo, Kai Ove, Planagumà, Jesús, Reed, Rolf Kåre, Bjerkvig, Rolf, Miletic, Hrvoje, Enger, Per Øyvind, Rygh, Cecilie Brekke, Chekenya, Martha

Obtenir text complet Obtenir text complet Obtenir text complet

Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation per Moen, Ingrid, Jevne, Charlotte, Wang, Jian, Kalland, Karl-Henning, Chekenya, Martha, Akslen, Lars A, Sleire, Linda, Enger, Per Ø, Reed, Rolf K, Øyan, Anne M, Stuhr, Linda EB

Obtenir text complet Obtenir text complet Obtenir text complet

Gamma Knife Surgery as Monotherapy with Clinically Relevant Doses Prolongs Survival in a Human GBM Xenograft Model per Sandvei Skeie, Bente, Wang, Jian, Dodoo, Ernest, Heggdal, Jan Ingeman, Grønli, Janne, Sleire, Linda, Bragstad, Sidsel, Ganz, Jeremy C., Chekenya, Martha, Mørk, Sverre, Pedersen, Paal-Henning, Enger, Per Øyvind

Obtenir text complet Obtenir text complet Obtenir text complet

Dynamic Contrast Enhanced MRI Detects Early Response to Adoptive NK Cellular Immunotherapy Targeting the NG2 Proteoglycan in a Rat Model of Glioblastoma per Rygh, Cecilie Brekke, Wang, Jian, Thuen, Marte, Gras Navarro, Andrea, Huuse, Else Marie, Thorsen, Frits, Poli, Aurelie, Zimmer, Jacques, Haraldseth, Olav, Lie, Stein Atle, Enger, Per Øyvind, Chekenya, Martha

Obtenir text complet Obtenir text complet Obtenir text complet

Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival per Gras Navarro, Andrea, Espedal, Heidi, Joseph, Justin Vareecal, Trachsel-Moncho, Laura, Bahador, Marzieh, Tore Gjertsen, Bjørn, Klæboe Kristoffersen, Einar, Simonsen, Anne, Miletic, Hrvoje, Øyvind Enger, Per, Rahman, Mohummad Aminur, Chekenya, Martha

Obtenir text complet Obtenir text complet Obtenir text complet

Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival per Poli, Aurélie, Wang, Jian, Domingues, Olivia, Planagumà, Jesús, Yan, Tao, Rygh, Cecilie Brekke, Skaftnesmo, Kai Ove, Thorsen, Frits, McCormack, Emmet, Hentges, François, Pedersen, Paal Henning, Zimmer, Jacques, Enger, Per Øyvind, Chekenya, Martha

Obtenir text complet Obtenir text complet

Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival per Rahman, Mohummad Aminur, Gras Navarro, Andrea, Brekke, Jorunn, Engelsen, Agnete, Bindesbøll, Christian, Sarowar, Shahin, Bahador, Marzieh, Bifulco, Ersilia, Goplen, Dorota, Waha, Andreas, Lie, Stein Atle, Gjertsen, Bjørn Tore, Selheim, Frode, Enger, Per Øyvind, Simonsen, Anne, Chekenya, Martha

Obtenir text complet Obtenir text complet Obtenir text complet

Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study per Rahman, Mohummad A., Brekke, Jorunn, Arnesen, Victoria, Hannisdal, Marianne H., Navarro, Andrea G., Waha, Andreas, Herfindal, Lars, Rygh, Cecilie B., Bratland, Eirik, Brandal, Petter, Haasz, Judit, Oltedal, Leif, Miletic, Hrvoje, Lundervold, Arvid, Lie, Stein A., Goplen, Dorota, Chekenya, Martha

Obtenir text complet Obtenir text complet Obtenir text complet

Angiogenesis-independent tumor growth mediated by stem-like cancer cells per Sakariassen, Per Ø., Prestegarden, Lars, Wang, Jian, Skaftnesmo, Kai-Ove, Mahesparan, Rupavathana, Molthoff, Carla, Sminia, Peter, Sundlisæter, Eirik, Misra, Anjan, Tysnes, Berit Bølge, Chekenya, Martha, Peters, Hans, Lende, Gabriel, Kalland, Karl Henning, Øyan, Anne M., Petersen, Kjell, Jonassen, Inge, van der Kogel, Albert, Feuerstein, Burt G., Terzis, A. Jorge A., Bjerkvig, Rolf, Enger, Per Øyvind

Obtenir text complet Obtenir text complet Obtenir text complet